APO 040
Pill imprint APO 040 has been identified as Omeprazole delayed release 40 mg.
Omeprazole is used in the treatment of gerd; stomach ulcer; indigestion; erosive esophagitis; helicobacter pylori infection (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy.
Omeprazole 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Omeprazole delayed release Images
- Imprint:
-
APO
040 - Strength:
- 40 mg
- Color:
- Pink / Brown
- Size:
- 21.00 mm
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- magnesium hydroxide
mannitol
methacrylic acid - ethyl acrylate copolymer (1:1) type a
povidone
triethyl citrate
gelatin
ferric oxide red
titanium dioxide
ammonia
ferrosoferric oxide
alcohol
isopropyl alcohol
butyl alcohol
potassium hydroxide
propylene glycol
shellac
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0146
Advertisement
More Omeprazole Delayed Release resources
- Omeprazole
- Omeprazole Delayed-Release Capsules (Wolters Kluwer)
- Omeprazole Delayed-Release Tablets (Wolters Kluwer)
- Omeprazole Magnesium Delayed-Release Capsules (Wolters Kluwer)
- Omeprazole Suspension (Wolters Kluwer)
- omeprazole (Cerner Multum)
- omeprazole (Micromedex) - Includes Dosage Information
- Omeprazole (AHFS DI)
- Omeprazole (FDA)
- Omeprazole Tablets (FDA)
- Omesec Drug Facts (FDA)
- Omeprazole (Wolters Kluwer)
Search Again
